BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights

  March 26, 2026

   · 

  8 min read
• Press Releases

  eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026

  March 26, 2026

   · 

  3 min read
• Press Releases

  CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

  March 26, 2026

   · 

  29 min read
• Press Releases

  Seaport Therapeutics Announces Science Translational Medicine Peer-Reviewed Publication Featuring GlyphAlloTM (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans

  March 26, 2026

   · 

  6 min read
• Press Releases

  Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization

  March 26, 2026

   · 

  4 min read
• Press Releases

  Outlook Therapeutics Announces Closing of $5.0 Million Public Offering

  March 26, 2026

   · 

  5 min read
• Press Releases

  FibroBiologics Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Bid Price Requirement

  March 26, 2026

   · 

  3 min read
• Press Releases

  BeyondSpring Files 2025 Annual Report on Form 10-K

  March 26, 2026

   · 

  2 min read
• Press Releases

  PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo™ (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans

  March 26, 2026

   · 

  10 min read
• Press Releases

  Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update

  March 26, 2026

   · 

  14 min read